These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3146942

  • 1. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
    Fourcade RO, Giuliano F.
    Ann Urol (Paris); 1988; 22(6):404-6. PubMed ID: 3146942
    [Abstract] [Full Text] [Related]

  • 2. [Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?].
    Egghart G, Steegmüller O, Wenderoth U, Hautmann R.
    Urologe A; 1988 May; 27(3):147-51. PubMed ID: 3136576
    [Abstract] [Full Text] [Related]

  • 3. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 4. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E, Jauhiainen K, Alfthan O.
    Prog Clin Biol Res; 1989 Mar; 310():271-4. PubMed ID: 2505270
    [No Abstract] [Full Text] [Related]

  • 5. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP, DeBruyne FM.
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [Abstract] [Full Text] [Related]

  • 6. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 7. [Mitomycin C in the topical treatment of superficial neoplasms of the bladder].
    Milani C, Bassi PF, Meneghini A, Giunta A, Tejerizo JC, dal Bianco M, Zattoni F, Garbeglio A.
    Arch Esp Urol; 1989 Oct; 42(8):761-7. PubMed ID: 2515812
    [Abstract] [Full Text] [Related]

  • 8. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH, Bouffioux C, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1988 Oct; 269():525-37. PubMed ID: 3134663
    [No Abstract] [Full Text] [Related]

  • 9. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH, Lee C.
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [Abstract] [Full Text] [Related]

  • 10. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
    Ikeuchi T, Onodera Y, Kai Y.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):858-63. PubMed ID: 6426397
    [Abstract] [Full Text] [Related]

  • 11. Intravesical mitomycin C and superficial bladder tumors.
    Biserte J, Rigot JM, Mauroy B, Mazeman E.
    Prog Clin Biol Res; 1989 Apr; 303():411-5. PubMed ID: 2506555
    [No Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy of mitomycin C and cytosine arabinoside in superficial bladder tumors. 1. Evaluation of intravesical infusion therapy].
    Ikeuchi T, Onodera Y, Kai Y.
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2145-51. PubMed ID: 6414383
    [Abstract] [Full Text] [Related]

  • 13. Re: Recurrence of superficial bladder carcinoma after intravesical instillation of Mitomycin-C.
    Parmar MK.
    Br J Urol; 1989 Dec; 64(6):659. PubMed ID: 2516758
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
    Liberti M, Tenaglia R, De Berardinis E, Gentile V.
    Minerva Med; 1984 Feb 28; 75(8):391-4. PubMed ID: 6424059
    [Abstract] [Full Text] [Related]

  • 18. [Cytoscopic follow-up of initial G3T1 bladder tumors treated with BCG].
    Pieras Ayala E, Palou J, Rodríguez-Villamil L, Millán Rodríguez F, Salvador Bayarri J, Vicente Rodríguez J.
    Arch Esp Urol; 2001 Apr 28; 54(3):211-7. PubMed ID: 11432035
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
    Schwarzman MI, Johanson KE, Surya B, Brown J.
    Urology; 1988 Oct 28; 32(4):335-8. PubMed ID: 3140465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.